Picibanil (OK-432)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Picibanil (OK-432), covering 2015-03-25 to 2015-03-25. Get the full timeline:
Most recent: Clinical Trial Update: Study of Picibanil (OK432) Sclerotherapy in Children With Macrocystic Lymphatic Malformations [Phase 2, Phase 3]